A carregar...
Burden of illness and research investments in translational sciences for pharmaceuticals in metastatic cancers
AIM: To explore whether investments in translational sciences for six metastatic cancers follow idiosyncratic returns to those investments rather than levels of burden of illness (BI). METHODS: Associate the number of translational clinical trials in the USA involving oncolytic drugs approved during...
Na minha lista:
| Publicado no: | J Comp Eff Res |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Future Medicine Ltd
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5220454/ https://ncbi.nlm.nih.gov/pubmed/27934549 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/cer-2016-0021 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|